Exploring sex differences in trajectories of pubertal development and mental health following early adversity
Psychoneuroendocrinology · 2024
DOI: 10.1016/j.psyneuen.2023.106944 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychoneuroendocrinology, 2024. Verfasst von Tiffany C Ho und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, University of California, Los Angeles, Los Angeles, CA, United States. Hauptthemen laut MEDLINE: Mental Health, Sex Characteristics. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, National Institutes of Health, National Institute of Mental Health.
Abstract (Originalsprache)
Despite evidence that early life adversity (ELA) affects mental health in adolescence, we know little about sex differences in how distinct dimensions of adversity affect development and their corresponding effects on mental health. In this three-wave longitudinal study, 209 participants (118 females; ages 9-13 years at baseline) provided objective (salivary hormones, BMI, age of menarche) and subjective (perceived gonadal and adrenal status) measures of puberty and physical development, and reported on levels of internalizing and externalizing symptoms at all timepoints. Participants also reported lifetime exposure to three distinct types of ELA: deprivation, threat, and unpredictability. Using generalized additive mixed models, we tested within each sex whether dimensions of adversity were associated with longitudinal changes in measures of pubertal and physical development, and whether these indices of development were associated with trajectories of internalizing and externalizing symptoms. In females, experiences of threat and unpredictability were significantly associated with earlier pubertal timing (e.g., age of menarche) whereas experiences of deprivation were associated with steeper increases in BMI; further, faster pubertal tempo (i.e., steeper increases in pubertal stage) was associated with increases in internalizing and externalizing symptoms. In males, however, ELA was not associated with any measures of pubertal or physical development or with symptoms. Together, our results suggest that adverse experiences during early life have sex-selective consequences for pubertal and physical maturation and mental health trajectories in ways that may elucidate why females are at higher risk for mental health difficulties during puberty, particularly following exposure to unpredictable and threatening experiences of adversity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychology, University of California, Los Angeles, Los Angeles, CA, United States.
- Department of Psychology, Stanford University, Stanford, CA, United States.
- Department of Psychological Sciences, University of Connecticut, Storrs, CT, United States.
- Department of Psychology, Stanford University, Stanford, CA, United States. Electronic address: iang@stanford.edu.
Förderung
- NIMH NIH HHS
- National Institutes of Health
- National Institute of Mental Health
- Klingenstein Third Generation Foundation
Zitieren
APA
Ho, T. C., Buthmann, J., Chahal, R., Miller, J. G., & Gotlib, I. H. (2024). Exploring sex differences in trajectories of pubertal development and mental health following early adversity. Psychoneuroendocrinology. https://doi.org/10.1016/j.psyneuen.2023.106944
Vancouver
Ho TC, Buthmann J, Chahal R, Miller JG, Gotlib IH. Exploring sex differences in trajectories of pubertal development and mental health following early adversity. Psychoneuroendocrinology. 2024. doi:10.1016/j.psyneuen.2023.106944
BibTeX
@article{Ho2024,
author = {Ho, Tiffany C and Buthmann, Jessica and Chahal, Rajpreet and Miller, Jonas G and Gotlib, Ian H},
title = {Exploring sex differences in trajectories of pubertal development and mental health following early adversity},
journal = {Psychoneuroendocrinology},
year = {2024},
doi = {10.1016/j.psyneuen.2023.106944}
}
EUVIMED